Skip to main content

Advertisement

Table 2 Input variables used in estimating health care costs

From: Government use licenses in Thailand: an assessment of the health and economic impacts

Parameters USD/yr References
EFV-based ARVs treatment 1,922 [44]
NVP-based ARVs treatment 3,087 [44]
LPV/r-based ARVs treatment 910 DMSIC
IDV/r-based ARVs treatment 1,210 DMSIC
clopidogrel plus aspirin for secondary prevention of ischemic heart disease 19 DMSIC
aspirin alone for secondary prevention of ischemic heart disease 2 DMSIC
letrozole for treatment of breast cancer 78 DMSIC
tamoxifen for treatment of breast cancer 111 DMSIC
docetaxel for treatment of breast cancer 225 DMSIC
paclitaxel for treatment of breast cancer 1,826 DMSIC
docetaxel for treatment of lung cancer 188 DMSIC
pemetrexed for treatment of lung cancer 5,470 DMSIC
erlotinib for treatment of lung cancer 2,684 DMSIC